hotspot -WSS

hotspot

author：fashion 2025-08-23 08:53:10 - browse：5

Adam's take main illustration — Molly Ferguson/STAT

MoonLake Immunotherapeutics, a Swiss biotech, was buried Monday under an avalanche of its own data spin.

It’s been awhile since I encountered a management team that speaks so arrogantly about the supposed supremacy of its own drug, but then fails to back up the talk with real data. MoonLake claimed its experimental antibody called sonelokimab delivered “landmark” results in a mid-stage study of psoriatic arthritis.

Landmark? That’s a strange way of describing the results of a clinical trial that showed sonelokimab topping a placebo — an easy hurdle — but failing to separate from an active treatment comparator, the generic drug adalimumab (known better as Humira).

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： At least 13 dead in Texas as scorching temps continue

WSS

Philips to halt sales of sleep apnea machines in U.S.

Investment in vaccine development is lagging, report finds

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Jerome Adams on the need for new antivirals for Covid

As demand for Covid shots wanes, Moderna seeks its next success

Humana’s losses in Medicare Advantage tank its stock

leisure time

hotspot

leisure time

After affirmative action ruling, medical educators look to 'holistic review'

Vertex non

Medical leaders decry Supreme Court decision on affirmative action

Humana’s losses in Medicare Advantage tank its stock

Medical records are filled with copy

Wildfire smoke exposes gaps in outdoor worker protections

State Dept. review finds Biden bears some blame for Afghanistan failures

Affirmative action in medical school literally saved lives

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Vertex non

hotspot

New clues to why women have higher risk of autoimmune disorders

Venture capital firm's plans to take over Akron hospital face hurdles

Boston competes with Raleigh

Continuity nursing helped my family in our darkest PICU moments

Bernie Sanders is gearing up to subpoena pharma CEOs

Biogen walks away from Aduhelm, years after polarizing approval

knowledge

explore

explore

entertainment